Hepatitis C
Showing NaN - NaN of 57
HCV-TARGET- Hepatitis C Therapeutic Registry and Research
Active, not recruiting
- Hepatitis C
-
Phoenix, Arizona
- +59 more
Oct 5, 2022
Blood From Healthy Patients, Benign Disease and Cancer
Recruiting
- Cancer
- +6 more
- Multi-analyte Blood Test
-
Redondo Beach, California
- +6 more
Aug 16, 2022
HIV, Hepatitis C Trial in Puerto Rico, United States (Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT), Dasabuvir (DSV), Ribavirin
Terminated
- HIV Infections
- Hepatitis C
- Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT)
- +2 more
-
Birmingham, Alabama
- +15 more
Nov 2, 2021
HIV, Hepatitis C Trial in Puerto Rico, United States (Pegylated-Interferon Alfa 2b (PEG-IFN), Ribavirin (RBV), Boceprevir (BOC))
Completed
- HIV Infections
- Hepatitis C
- Pegylated-Interferon Alfa 2b (PEG-IFN)
- +2 more
-
Birmingham, Alabama
- +42 more
Nov 2, 2021
An Observational Study of Hepatitis C Virus in Pregnancy
Completed
- Hepatitis C
-
Birmingham, Alabama
- +16 more
Sep 21, 2021
Direct Acting Antiviral-Post Authorization Safety Study
Completed
- Hepatitis C
- Hepatocellular Carcinoma
-
Phoenix, Arizona
- +61 more
Jul 1, 2021
Hepatitis C, HepatoCellular Carcinoma Trial in Dallas (Mailed outreach)
Completed
- Hepatitis C
- HepatoCellular Carcinoma
- Mailed outreach
-
Dallas, TexasParkland Hospital
Apr 16, 2021
Hepatitis C, Transplantation Disease Transmission Trial in United States (Sofosbuvir/Velpatasvir,
Completed
- Hepatitis C
- Transplantation Disease Transmission
-
San Francisco, California
- +5 more
Feb 10, 2021
Liver Diseases, Alcoholic, Alcoholism, HIV Trial in United States (Integrated Stepped Care (ISC), Treatment as Usual)
Completed
- Liver Diseases, Alcoholic
- +3 more
- Integrated Stepped Care (ISC)
- Treatment as Usual
-
Washington, District of Columbia
- +4 more
Nov 5, 2020
Hepatitis C, HIV, AIDS Trial in United States (Control Group, Care Facilitation Group)
Completed
- Hepatitis C
- +3 more
- Control Group
- Care Facilitation Group
-
Birmingham, Alabama
- +10 more
Jul 21, 2020
Hepatitis C, Hepatocellular Carcinoma Trial in Dallas (Mailed Outreach)
Withdrawn
- Hepatitis C
- Hepatocellular Carcinoma
- Mailed Outreach
-
Dallas, TexasParkland Hospital
Jun 30, 2020
Thrombocytopenia, Hepatitis C Trial in Dallas (Eltrombopag)
Terminated
- Thrombocytopenia
- Hepatitis C
-
Dallas, TexasUT Southwestern Medical Center
Oct 30, 2019
Hepatitis C, Hepatitis C, Chronic, Nonimmune Nonviral Causes of Liver Failure Trial in United States (drug, procedure, other)
Completed
- Hepatitis C
- +2 more
- calcineurin inhibitor-based immunosuppression
- +3 more
-
San Francisco, California
- +7 more
Jan 15, 2019
End Stage Liver Disease, Hepatitis C Trial in Dallas (Daclizumub, Tacrolimus, Cyclosporine)
Completed
- End Stage Liver Disease
- Hepatitis C
- Daclizumub
- +3 more
-
Dallas, TexasBaylor Regional Transplant Institute - Baylor University Medical
Nov 15, 2016
Hepatitis C, MDD Trial in Dallas (Exercise, Health Education)
Terminated
- Hepatitis C
- Major Depressive Disorder
- Exercise
- Health Education
-
Dallas, TexasUT Southwestern Medical Center
Dec 28, 2016